These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30025458)

  • 21. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
    Lev N; Melamed E; Offen D
    Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
    Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
    ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease.
    Hu Q; Uversky VN; Huang M; Kang H; Xu F; Liu X; Lian L; Liang Q; Jiang H; Liu A; Zhang C; Pan-Montojo F; Zhu S
    Biochim Biophys Acta; 2016 Oct; 1862(10):1883-90. PubMed ID: 27425033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers.
    Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
    Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
    Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinsonism due to A53E α-synuclein gene mutation: Clinical, genetic, epigenetic, and biochemical features.
    Picillo M; Lizarraga KJ; Friesen EL; Chau H; Zhang M; Sato C; Rooke G; Munhoz RP; Rogaeva E; Fraser PE; Kalia SK; Kalia LV
    Mov Disord; 2018 Dec; 33(12):1950-1955. PubMed ID: 30423204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Models of α-synuclein aggregation in Parkinson's disease.
    Giráldez-Pérez R; Antolín-Vallespín M; Muñoz M; Sánchez-Capelo A
    Acta Neuropathol Commun; 2014 Dec; 2():176. PubMed ID: 25497491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
    Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
    Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. V63 and N65 of overexpressed α-synuclein are involved in mitochondrial dysfunction.
    Zhang H; Liu J; Wang X; Duan C; Wang X; Yang H
    Brain Res; 2016 Jul; 1642():308-318. PubMed ID: 27048753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
    Sanjeev A; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.
    Khalife M; Morshedi D; Aliakbari F; Tayaranian Marvian A; Mohammad Beigi H; Azimzadeh Jamalkandi S; Pan-Montojo F
    Protein J; 2015 Aug; 34(4):291-303. PubMed ID: 26250981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells.
    Shavali S; Brown-Borg HM; Ebadi M; Porter J
    Neurosci Lett; 2008 Jul; 439(2):125-8. PubMed ID: 18514418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
    Benskey MJ; Perez RG; Manfredsson FP
    J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone].
    Liu YY; Zhao HY; Zhao CL; Duan CL; Lu LL; Yang H
    Sheng Li Xue Bao; 2006 Oct; 58(5):421-8. PubMed ID: 17041725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct higher-order α-synuclein oligomers induce intracellular aggregation.
    Illes-Toth E; Ramos MR; Cappai R; Dalton C; Smith DP
    Biochem J; 2015 Jun; 468(3):485-93. PubMed ID: 25851527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's disease.
    Macchi F; Deleersnijder A; Van den Haute C; Munck S; Pottel H; Michiels A; Debyser Z; Gerard M; Baekelandt V
    J Neurosci Methods; 2016 Mar; 261():117-27. PubMed ID: 26620202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.